More than 6.8M doses of the vaccine have been administered in the U.S., most with no or mild side effects
Officials have indicated there could be a similar delay in the delivery of 1.2 million doses from Moderna next week
Concerns have already prompted some countries including Canada, France, Germany and the Netherlands to restrict its use to older people
More than 247,000 people have died of COVID-19 in the U.S. since vaccines first became available mid-December
The World Health Organization has urged countries to continue using the jab
The study is testing the safety and efficacy of both one-dose and two-dose regimens of the vaccine
Canada approved the vaccine in early March and had pre-ordered 10 million doses
The new facility’s work will include drug product formulation, fill-and-finish and inspection of flu vaccines
Researchers reported high levels of antibodies, higher than were seen in studies of young adults
Only 53% said they would trust the AstraZeneca vaccine being given to themselves or family members
Dr. Tam says hospitalizations are up 6% in the last week and number of patients in ICU is up 14%
Provinces are acting on a committee’s concerns about a possible link between the shot and rare blood clots
The two vaccines available since December — Pfizer and Moderna — were highly effective at 90% after two doses,
This would mark the single-largest week of deliveries into Canada since the start of the pandemic
A sixth vaccine from Novavax is still under review, with the results not expected until next month
Sixty per cent of Canadians over the age of 80 have received at least one dose
Officials say they are on track to receive 9.5 million doses by end of March
